Compare MPB & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MPB | CBLL |
|---|---|---|
| Founded | 1868 | 2014 |
| Country | United States | United States |
| Employees | N/A | 280 |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 827.5M | 750.1M |
| IPO Year | 1996 | N/A |
| Metric | MPB | CBLL |
|---|---|---|
| Price | $34.64 | $19.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $37.00 | $23.20 |
| AVG Volume (30 Days) | 127.9K | ★ 287.2K |
| Earning Date | 04-21-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.36 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.95 | $29.57 |
| Revenue Next Year | $9.45 | $28.44 |
| P/E Ratio | $94.89 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.50 | $10.85 |
| 52 Week High | $35.22 | $24.33 |
| Indicator | MPB | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 56.49 | 61.45 |
| Support Level | $32.81 | $18.91 |
| Resistance Level | $34.82 | $21.51 |
| Average True Range (ATR) | 0.69 | 0.82 |
| MACD | 0.07 | 0.22 |
| Stochastic Oscillator | 71.99 | 74.80 |
Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.